The value of dual time point 11C-choline PET-CT in differentiating malignant from benign lesion of mediastinum

National Medical Journal of China

Volumn 87, Issue 47, 2007, Pages 3317-3320

  Peng, Zhong Min ^a   Liu, Qi ^a   Liu, Qing Wei ^a   Yao, Shu Zhan ^a   Meng, Long ^a   Liu, Qian ^a   Chen, Jing Han ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Lung neoplasms; Mediastinal diseases; Mediastinoscopy; Tomography, emission computed

Indexed keywords

CARBON 11; CHOLINE; TRACER;

ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SARCOIDOSIS; LUNG TUBERCULOSIS; LYMPH NODE METASTASIS; LYMPHOMA; MEDIASTINOSCOPY; MEDIASTINUM CANCER; MEDIASTINUM DISEASE; POSITRON EMISSION TOMOGRAPHY;

ADULT; AGED; CARBON RADIOISOTOPES; CHOLINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDIASTINAL DISEASES; MEDIASTINAL NEOPLASMS; MEDIASTINOSCOPY; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 40549085386     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Venissac N, Alifano M, Mouroux J. Video-assisted mediastinoscopy: experience from 240 consecutive cases. Ann Thorac Surg, 2003, 76:208-212.
2. Chinese source.
3. Detterbeck FC, Falen S, Rivera MP, et al. Seeking a home for a PET, part 2: Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer. Chest, 2004, 125:2300-2308.
4. 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging, 2004, 31:1064-1072.
5. Silvestri GA, Tanoue LT, Margolis ML, et al. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest, 2003, 123:147S-156S.
6. Chinese source.
7. Scanagatta P, Bonadiman C, Falezza G, et al. Mediastinoscopy for diagnosis of diseases of the chest and staging of lung cancer: our experience in 253 cases. Chir Ital, 2005, 57:177-182.
8. Spaggiari L, Sverzellati N, Versari A, et al. Evaluation of N parameter in the staging of non-small cell lung cancer: role of CT and PET. Radiol Med (Torino), 2005, 109:449-459.
9. Larson SM, Nehmeh SA, Erdi YE, et al. PET/CT in non-small-cell lung cancer: value of respiratory-gated PET. Chang Gung Med J, 2005, 28:306-314.
10. 1C-choline PET. J Nucl Med, 2000, 41:1507-1513.
11. Aiken NR, Gillies RJ. Phosphomonoester metabolism as a function of cell proliferative status and exogenous precursors. Anticancer Res, 1996, 16:1393-1397.
12. 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study. Chest, 2003, 124:893-901.
13. 18F-FDG PET for the diagnosis of thoracic malignancy. Nucl Med Commun, 2003, 24:1129-1137.
14. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med, 2001, 42:1412-1417.
15. 18SF-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. J Nucl Med, 2006, 47:1440-1446.
16. 18FDG uptake in soft tissue masses. Eur J Nucl Med, 1999, 26:22-30.
17. 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med, 2002, 43:871-875.
18. Hickeson M, Zhuang HM, Chacko T, et al. Superiority of dual versus single time point FDG PET imaging in the assessment of pulmonary nodules. J Nucl Med, 2002, 43 suppl:155.